An oncolytic adenovirus enhanced for Toll-like receptor 9 stimulation increases anti-tumor immune responses and reduces myeloid-derived suppressor cell activity

被引：0
|
作者：
Cerullo, V. [1 ]
Diaconu, I. [1 ]
Vaha-Koskela, M. [1 ]
Romano, V. [1 ]
Ugolini, M. [1 ]
Rouvinen-Lagerstrom, N. [1 ]
Escutenaire, S. [1 ]
Holm, S-L [1 ]
Pesonen, S. [1 ]
Vile, R. [2 ]
Kanerva, A. [1 ]
Hemminki, A. [1 ]
机构：
[1] Univ Helsinki, Canc Gene Therapy Grp, FIN-00290 Helsinki, Finland
[2] Mayo Clin, Dept Immunol, Rochester, MN USA
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [1] An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
    Cerullo, Vincenzo
    Diaconu, Iulia
    Romano, Valentina
    Hirvinen, Mari
    Ugolini, Matteo
    Escutenaire, Sophie
    Holm, Sirkka-Liisa
    Kipar, Anja
    Kanerva, Anna
    Hemminki, Akseli
    MOLECULAR THERAPY, 2012, 20 (11) : 2076 - 2086
  • [2] Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
    Shime, Hiroaki
    Maruyama, Akira
    Yoshida, Sumito
    Takeda, Yohei
    Matsumoto, Misako
    Seya, Tsukasa
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [3] A BRAF inhibitor and a Toll-like receptor 7 agonist synergistically enhanced anti-tumor immune responses
    Nakamura, K.
    Yaguchi, T.
    Murata, M.
    Ota, Y.
    Kiniwa, Y.
    Okuyama, R.
    Kawakami, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S133 - S133
  • [4] Inflammation enhances myeloid-derived suppressor cell crosstalk by signaling through Toll-like receptor 4
    Bunt, Stephanie K.
    Clements, Virginia K.
    Hanson, Erica M.
    Sinha, Pratima
    Ostrand-Rosenberg, Suzanne
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 85 (06) : 996 - 1004
  • [5] Effect of BCNU on myeloid-derived suppressor cells in anti-tumor immune response
    Zhou, Juhua
    Nagarkatti, Prakash
    Zhong, Yin
    Nagarkatti, Mitzi
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [6] Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
    Tao, Huimin
    Liu, Mingyu
    Wang, Yuan
    Luo, Shufeng
    Xu, Yongquan
    Ye, Bin
    Zheng, Limin
    Meng, Kun
    Li, Lian
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Anti-tumor Activity of Toll-Like Receptor 7 Agonists
    Chi, Huju
    Li, Chunman
    Zhao, Flora Sha
    Zhang, Li
    Ng, Tzi Bun
    Jin, Guangyi
    Sha, Ou
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [8] Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer
    Zhou, Hongyue
    Jiang, Mengyu
    Yuan, Hongyan
    Ni, Weihua
    Tai, Guixiang
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [9] Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
    Huang, Zhen
    Yang, Yang
    Jiang, Yucui
    Shao, Juan
    Sun, Xulun
    Chen, Jiangning
    Dong, Lei
    Zhang, Junfeng
    BIOMATERIALS, 2013, 34 (03) : 746 - 755
  • [10] Cutaneous Innate Immune Sensing of Toll-like Receptor 2-6 Ligands Suppresses T Cell Immunity by Inducing Myeloid-Derived Suppressor Cells
    Skabytska, Yuliya
    Woelbing, Florian
    Guenther, Claudia
    Koeberle, Martin
    Kaesler, Susanne
    Chen, Ko-Ming
    Guenova, Emmanuella
    Demircioglu, Doruk
    Kempf, Wolfgang E.
    Volz, Thomas
    Rammensee, Hans-Georg
    Schaller, Martin
    Roecken, Martin
    Goetz, Friedrich
    Biedermann, Tilo
    IMMUNITY, 2014, 41 (05) : 762 - 775
12345